Shield Therapeutics (STX) News Today GBX 3.66 -0.14 (-3.55%) As of 02/21/2025 11:24 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Shield Therapeutics plc (LON:STX) Insider Anders Lundstrom Acquires 575,000 Shares of StockFebruary 15, 2025 | americanbankingnews.comInsider Buying: Shield Therapeutics plc (LON:STX) Insider Acquires 575,000 Shares of StockFebruary 15, 2025 | insidertrades.comShield Therapeutics CEO Buys 575,000 Company SharesFebruary 13, 2025 | msn.comShield Therapeutics awards CEO share optionsFebruary 13, 2025 | msn.comShield Thera Regulatory NewsFebruary 9, 2025 | lse.co.ukTyneside pharma firm Shield Therapeutics appoints new US-based CEOJanuary 28, 2025 | msn.comEli Lilly to acquire Scorpion Therapeutics’ STX-478 program for up to $2.5BJanuary 13, 2025 | markets.businessinsider.comHardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakevenNovember 21, 2024 | markets.businessinsider.comShield Therapeutics plc (SHIEF)November 17, 2024 | finance.yahoo.comShield Therapeutics reports steady Q3 growth and financial plansOctober 31, 2024 | uk.investing.comShield Therapeutics lines up $15m finance deal and cost saving planOctober 30, 2024 | msn.comInsider Buyers At Shield Therapeutics Recover Some Losses, But Still Down US$28kOctober 16, 2024 | finance.yahoo.comShield Therapeutics: Strong Accrufer Sales Growth Amidst Rising Costs and Market Penetration ChallengesSeptember 26, 2024 | markets.businessinsider.comWhy Zelda: Echoes of Wisdom Doesn't Feature Link as the Main Playable CharacterSeptember 25, 2024 | msn.comShield Therapeutics PLC STX (U.K.: London)September 19, 2024 | wsj.comShield TherapeuticsSeptember 12, 2024 | fool.co.ukShield Therapeutics builds revenues as US prescriptions growSeptember 4, 2024 | msn.comShield Therapeutics to enter Canadian market following approval of iron deficiency drugAugust 28, 2024 | msn.comBoss of drugs firm Shield Therapeutics steps down as US prescriptions ramp upJuly 24, 2024 | msn.comShield Therapeutics CEO Greg Madison To Step DownJuly 24, 2024 | markets.businessinsider.comKorean market is latest play for Shield Therapeutics' iron deficiency drugMay 28, 2024 | msn.comInsider Traders Lose US$91k As Shield Therapeutics DropsMay 9, 2024 | finance.yahoo.comGalera Therapeutics Implements Stockholder Rights Plan to Shield Investor InterestsMay 3, 2024 | msn.comTurning a tumor's 'shield' into a weapon against itselfMay 2, 2024 | msn.comNeutral Switzerland joins European Sky Shield defence projectApril 10, 2024 | msn.comAmerican Home Shield Offering 40% Off ShieldGold™ For Limited TimeApril 1, 2024 | tmcnet.comA Real Life Invisibility Shield for Privacy in Public PlacesMarch 29, 2024 | msn.comSeal Shield to Showcase Shyld AI, the World's First Intelligent, Autonomous, UV-C Disinfection System at HIMSS 2024March 11, 2024 | tmcnet.comLONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutesFebruary 23, 2024 | lse.co.ukShield Therapeutics PLC STXFebruary 22, 2024 | morningstar.comShield Therapeutics plc (STX.L)February 13, 2024 | uk.finance.yahoo.comShield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years agoJanuary 24, 2024 | finance.yahoo.comShield Therapeutics plc (LON:STX) Is Expected To Breakeven In The Near FutureDecember 28, 2023 | finance.yahoo.comShield Therapeutics to present at NPWH conference this monthOctober 20, 2023 | proactiveinvestors.comShield Therapeutics CFO Hans-Peter Rudolf to Step DownOctober 12, 2023 | marketwatch.comShield Therapeutics launches executive search process as CFO steps downOctober 12, 2023 | proactiveinvestors.comShield Therapeutics "couldn't be more pleased" with Viatris collaborationOctober 5, 2023 | finance.yahoo.comShield Therapeutics' pricing will be "key metric" - Proactive Research AnalystOctober 5, 2023 | finance.yahoo.comShield Therapeutics secures debt facility, retail share offer closes soonOctober 3, 2023 | proactiveinvestors.comShield Therapeutics First Half 2023 Earnings: US$0.025 loss per share (vs US$0.069 loss in 1H 2022)September 30, 2023 | finance.yahoo.comShield Therapeutics hails progress in Stateside venture as losses narrowSeptember 29, 2023 | msn.comShield Therapeutics Shares Fall After Discounted Equity RaiseSeptember 28, 2023 | marketwatch.comPrivate companies who hold 41% of Shield Therapeutics plc (LON:STX) gained 17%, institutions profited as wellSeptember 5, 2023 | finance.yahoo.comShield Therapeutics : First signs of hoped-for Accrufer Rx inflectionJuly 29, 2023 | proactiveinvestors.comHardman & Co Research on Shield Therapeutics (STX): Accrufer Rx momentum gatheringJuly 25, 2023 | finanznachrichten.deShield Therapeutics "really starting to fire on all cylinders"July 25, 2023 | finance.yahoo.comShield Therapeutics Shares Rise as US Prescriptions for Accrufer SoarJuly 20, 2023 | marketwatch.comShield Therapeutics makes waves in US as iron deficiency prescriptions ramp upJuly 20, 2023 | msn.comShield Therapeutics reports 173% Accrufer prescription growthJuly 20, 2023 | proactiveinvestors.comSave $30 on the Nvidia Shield Android TV for Amazon Prime DayJuly 11, 2023 | msn.com Get Shield Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter. Email Address STX Media Mentions By Week STX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STX News Sentiment▼1.220.60▲Average Medical News Sentiment STX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STX Articles This Week▼00▲STX Articles Average Week Get Shield Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VLG News Today EAH News Today CEL News Today CHLL News Today HELD News Today HLN News Today BXP News Today HIK News Today HCM News Today INDV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:STX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shield Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Shield Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
